Utility of PCD Diagnostics to Improve Clinical Care



Status:Recruiting
Healthy:No
Age Range:1 - Any
Updated:10/14/2018
Start Date:June 1, 2017
End Date:June 1, 2020
Contact:Michael O'Connor, MD
Email:michael.g.oconnor@vumc.org
Phone:615.343.7617

Use our guide to learn which trials are right for you!

This is a study evaluating the utility of current Primary Ciliary Dyskinesia (PCD) diagnostic
tests, including nasal nitric oxide testing.

This study is a prospective data collection of individuals referred to the investigators
clinical center for considerations of PCD. Participants sign informed consent to have
clinical information entered into a secure electronic database. As part of this study,
participants may have nasal nitric oxide (nNO) testing performed. nNO testing is a research
procedure, but it is a test with growing utility for making a diagnosis of PCD when performed
in the right clinical setting.

Inclusion Criteria:

- Referred to center for PCD diagnosis considerations

- Ability to perform study procedures

- Age greater than 2 years of age

Exclusion Criteria:

- Age less than 2 years of age Inability to perform informed consent
We found this trial at
1
site
2200 Children's Way
Nashville, Tennessee 37232
(615) 936-1000
Vanderbilt Children's Hospital Monroe Carell Jr. Children's Hospital at Vanderbilt is one of the nation's...
?
mi
from
Nashville, TN
Click here to add this to my saved trials